Showing results (61-70 of 968) with videos related to
Sort By:
Pageof 97
Chinese Clinical Oncology|January 8, 2017
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trialsLindsay A Renfro, Daniel J SargentBritish Journal of Clinical Pharmacology|December 17, 2009
New central targets for the treatment of obesityBruce J Sargent, Nicholas A MooreCurrent Opinion in Pharmacology|February 19, 2011
Targeting 5-HT receptors for the treatment of obesityBruce J Sargent, Alan J HendersonJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
All-comers versus enrichment design strategy in phase II trialsSumithra J Mandrekar, Daniel J SargentClinical Investigation|March 6, 2012
Design of clinical trials for biomarker research in oncologySumithra J Mandrekar, Daniel J SargentStatistics in Medicine|June 15, 1996
Robust Bayesian approaches for clinical trial monitoringB P Carlin, D J SargentJournal of Biopharmaceutical Statistics|April 23, 2009
Clinical trial designs for predictive biomarker validation: one size does not fit allSumithra J Mandrekar, Daniel J SargentEuropean Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Optimising the design of phase II oncology trials: the importance of randomisationMark J Ratain, Daniel J SargentJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challengesSumithra J Mandrekar, Daniel J SargentProceedings of the National Academy of Sciences of the United States of America|April 21, 2022
Three world wars: Fiscal-monetary consequencesGeorge J Hall, Thomas J SargentPageof 97